When the body encounters a severe pathogen like the SARS-CoV-2 virus, the immune system launches a massive inflammatory response to neutralize the threat
Subsequently, brain insulin and Akt signaling pathways were also evaluated in neuronal-derived exosomes and it was shown that exenatide treatment, but not placebo, activated these pathways (Athauda et al
Gradual dose escalation often prevents severe side effects while maintaining therapeutic benefits
Using precise analytical methods, we determine peptide concentration to support reliable dosing and reproducibility
Eli Lilly and Company announced results from a late-stage clinical trial showing that its next-generation obesity treatment retatrutide delivered unprecedented weight-loss outcomes, outperforming its existing blockbuster drug Zepbound (tirzepatide)
SARS-CoV-2 markedly decreases the levels of cellular thiols, essentially lowering the reduced form of GSH